Physician profile
Eric D Bava
NPI 1114144284
$899.15
in general payments reported to CMS, 2019-2025
9 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.07 · 2020: $17.06 · 2021: $56.93 · 2022: $34.02 · 2023: $443 · 2024: $38.63 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $629.69 | 2022-2025 | Variax, T2 Alpha, Gamma |
| Fx Shoulder Solutions, INC | $49.29 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $41.76 | 2025 | Euflexxa |
| Wright Medical Technology, INC. | $38.84 | 2019 | |
| Ethicon US, LLC | $38.04 | 2021-2023 | Dermabond Prineo, Stratafix |
| Bioventus LLC | $35.61 | 2021-2022 | |
| Davol INC. | $33.01 | 2025 | Channel Drain |
| Heron Therapeutics, INC. | $16.53 | 2021 | |
| Zimmer Biomet Holdings, INC. | $16.38 | 2025 | Comprehensive Shoulder System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.